Headlines about Agilent Technologies (NYSE:A) have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Agilent Technologies earned a news impact score of 0.18 on Accern’s scale. Accern also gave headlines about the medical research company an impact score of 44.9282373655877 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the headlines that may have effected Accern’s rankings:

Agilent Technologies (A) opened at 63.90 on Thursday. The company’s 50 day moving average price is $60.73 and its 200 day moving average price is $56.62. The firm has a market cap of $20.58 billion, a PE ratio of 32.96 and a beta of 1.30. Agilent Technologies has a 52-week low of $42.92 and a 52-week high of $63.93.

Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the prior year, the firm earned $0.49 EPS. The company’s revenue was up 6.7% compared to the same quarter last year. Analysts predict that Agilent Technologies will post $2.32 earnings per share for the current fiscal year.

A number of brokerages have commented on A. Jefferies Group LLC boosted their target price on Agilent Technologies from $59.00 to $66.00 and gave the company a “buy” rating in a research note on Tuesday, May 23rd. Bank of America Corporation restated an “equal weight” rating on shares of Agilent Technologies in a research note on Tuesday, August 15th. BidaskClub downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Deutsche Bank AG boosted their target price on Agilent Technologies from $58.00 to $62.00 and gave the company a “buy” rating in a research note on Monday, May 22nd. Finally, Morgan Stanley restated an “overweight” rating on shares of Agilent Technologies in a research note on Wednesday, August 16th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Agilent Technologies currently has an average rating of “Buy” and a consensus price target of $63.18.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.watchlistnews.com/agilent-technologies-a-getting-somewhat-positive-press-coverage-analysis-finds/1532809.html.

In other news, CFO Didier Hirsch sold 72,545 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $62.38, for a total transaction of $4,525,357.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Patrick Kaltenbach sold 5,000 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $63.26, for a total transaction of $316,300.00. The disclosure for this sale can be found here. Insiders have sold a total of 116,598 shares of company stock valued at $7,232,598 over the last three months.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.